AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2023
Feb 2, 2023
31201_dirs_2023-02-02_fd766b24-7a0f-49a0-b1e1-4de55e6249b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2023-01-23
Reporting Person: Corcoran Nicholas (See Remarks)
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Earnings Release
2026
Feb 24
Director's Dealing
2026
Feb 20